ULTRAGENYX PHARMACEUTICAL INC revenue breakdown overview

ULTRAGENYX PHARMACEUTICAL INC revenue for the last year amounted to 7.38 B MXN, the most of which — 3.10 B MXN — came from its highest performing source at the moment, Crysvita Royalty, the year earlier bringing 423.09 M MXN. The greatest contribution to the revenue figure was made by North America — last year it brought ULTRAGENYX PHARMACEUTICAL INC 5.22 B MXN, and the year before that — 5.48 B MXN.